Tine K. Olesen
Copenhagen, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Follicle-stimulating hormone receptor expression in advanced atherosclerotic plaques.
Journal: Scientific reports
Published: November 14, 2023
Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial.
Journal: Circulation
Published: August 30, 2021
Assessment of the Most Impactful Combination of Factors Associated with Nocturia and to Define Nocturnal Polyuria by Multivariate Modelling.
Journal: Journal of clinical medicine
Published: June 06, 2020
Cardiovascular Safety of Degarelix Versus Leuprolide for Advanced Prostate Cancer: The PRONOUNCE Trial Study Design.
Journal: JACC. CardioOncology
Published: September 10, 2019
Identifying men with global polyuria on a nocturnal-only voiding diary.
Journal: Neurourology and urodynamics
Published: August 30, 2019
Development of a multivariate prediction model for nocturia, based on urinary tract etiologies.
Journal: International journal of clinical practice
Published: June 13, 2018
Systematic review of proposed definitions of nocturnal polyuria and population-based evidence of their diagnostic accuracy.
Journal: Acta clinica Belgica
Published: February 07, 2018
Follicle-Stimulating Hormone Receptor Expression in Endometriotic Lesions and the Associated Vasculature: An Immunohistochemical Study.
Journal: Reproductive sciences (Thousand Oaks, Calif.)
Published: December 26, 2015
Long-term tolerability and efficacy of degarelix: 5-year results from a phase III extension trial with a 1-arm crossover from leuprolide to degarelix.
Journal: Urology
Published: October 18, 2013
Cardiovascular morbidity associated with gonadotropin releasing hormone agonists and an antagonist.
Journal: European urology
Published: July 30, 2013
Rapid elimination kinetics of free PSA or human kallikrein-related peptidase 2 after initiation of gonadotropin-releasing hormone-antagonist treatment of prostate cancer: potential for rapid monitoring of treatment responses.
Journal: Clinical chemistry and laboratory medicine
Published: December 30, 2011
The effect of baseline testosterone on the efficacy of degarelix and leuprolide: further insights from a 12-month, comparative, phase III study in prostate cancer patients.
Journal: Urology
Published: December 05, 2011
Showing 1-12 of 12
Last Updated: 09/26/2026